The clinical efforts of W. Robert Lee, MD, MS, Med, are focused on the treatment of prostate cancer with radiotherapy (external beam or brachytherapy).
Current research interests include image-guided techniques that integrate bio-anatomic information into the treatment planning and delivery processes, indicators of quality in prostate brachytherapy, novel fractionation schemes in the treatment of prostate cancer, and the responsible integration of technology into medical education.
Lee is active within the radiation therapy oncology group (RTOG) and is the principal investigator of a phase II trial examining the combination of low dose-rate brachytherapy with external beam radiotherapy and a phase III trial comparing hypofractionated external beam radiotherapy to conventionally fractionated external beam radiotherapy.
He is also the primary investigator of a stereotactic body radiotherapy (SBRT) protocol examining the toxicity and efficacy of an extreme hypofractionated regimen (37 Gy in 5 fractions) using continuous target localization and online reoptimization.
W. Robert Lee, MD, MS, Med
Professor of Radiation Oncology
Associate Professor of Surgery
Duke University Medical Center
Durham, NC 27710